ISOMORPHIC LABS, the Ai Drug Business of Google, collects money from Thrive
                    In the last 12 months, Google's efforts for the use of artificial intelligence to accelerate the design of drugs have reached discoveries in the imitation of human biology and have won its best scientists the Nobel Prize in Chemistry.Now Isomorphic Labs, the division within the software giant, intended to develop and market technology, is taking another big step: to raise funds from an external investor.ISOMORPHIC plans to announce Monday that you have collected $ 600 million, led by Thrive Capital, the risk capital company that has largely bet for artificial intelligence companies including Openai. Even GV, Google and Alphabet's venture capital arm, Google's parent company, have invested.The announcement underlines Google's ambitions for ISOMORPHIC, which was broadcast by the company's De...                
                
            









